Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
22 20 Search
2025
Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme
Scientific Reports
2025
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Journal of Advanced Research
2025
Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas
Strahlentherapie und Onkologie
2023
Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression
Cancers
2023
Identification of Prognostic Aging-Related Genes Associated with Immune Cell Infiltration in Glioblastoma
Journal of Oncology
2022
ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
Journal of Clinical Laboratory Analysis
2022
Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
Frontiers in Immunology
2022
HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer
Cancers
2022
Analysis of the Mechanism of RAD18 in Glioma
Neuroimmunomodulation
2022
Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
Frontiers in Immunology
2022
Advances in Antitumor Strategies Targeting Tumor-Associated Macrophages
World Journal of Cancer Research
2022
Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
Frontiers in Oncology
2022
Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
Frontiers in Genetics
2021
Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer
Bioengineered
2021
Current Status of Tissue Clearing and the Path Forward in Neuroscience
ACS Chemical Neuroscience
2021
Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
Frontiers in Molecular Neuroscience
2021
Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
Frontiers in Oncology
2021
Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA
Journal of Oncology
2020
Immune-Related lncRNA Correlated with Transcription Factors Provide Strong Prognostic Prediction in Gliomas
Journal of Oncology
2020
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
Frontiers in Oncology
2020
Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
Frontiers in Cell and Developmental Biology
Additional cited-by details will be shown when available from Crossref